8 research outputs found
Human muscular fetal cells: a potential cell source for muscular therapies.
Myoblast transfer therapy has been extensively studied for a wide range of clinical applications, such as tissue engineering for muscular loss, cardiac surgery or Duchenne Muscular Dystrophy treatment. However, this approach has been hindered by numerous limitations, including early myoblast death after injection and specific immune response after transplantation with allogenic cells. Different cell sources have been analyzed to overcome some of these limitations. The object of our study was to investigate the growth potential, characterization and integration in vivo of human primary fetal skeletal muscle cells. These data together show the potential for the creation of a cell bank to be used as a cell source for muscle cell therapy and tissue engineering. For this purpose, we developed primary muscular cell cultures from biopsies of human male thigh muscle from a 16-week-old fetus and from donors of 13 and 30 years old. We show that fetal myogenic cells can be successfully isolated and expanded in vitro from human fetal muscle biopsies, and that fetal cells have higher growth capacities when compared to young and adult cells. We confirm lineage specificity by comparing fetal muscle cells to fetal skin and bone cells in vitro by immunohistochemistry with desmin and 5.1 H11 antibodies. For the feasibility of the cell bank, we ensured that fetal muscle cells retained intrinsic characteristics after 5 years cryopreservation. Finally, human fetal muscle cells marked with PKH26 were injected in normal C57BL/6 mice and were found to be present up to 4 days. In conclusion we estimate that a human fetal skeletal muscle cell bank can be created for potential muscle cell therapy and tissue engineering
Seasonal activity, vector relationships and genetic analysis of mosquito-borne Stratford virus
Mesenchymal Stromal Cell Secreted Sphingosine 1-Phosphate (S1P) Exerts a Stimulatory Effect on Skeletal Myoblast Proliferation
Arboviruses of Oceania
Arboviruses present an ongoing challenge to Oceanic nations. Viruses including Ross River, Barmah Forest and Murray Valley encephalitis are endemic to the region and are responsible for occasional outbreaks. Recent epidemics of chikungunya, Zika and dengue viruses across many nations demonstrate the vulnerability of this region to globally emergent arboviruses. In addition to global disease trends, the emergence of these viruses is largely driven by human influences such as water and waste management, air travel and land use. Limited public health resources and infrastructure, dispersed populations and the complexity of arbovirus ecologies complicate mitigation and management strategies in the Western Pacific. A regional collaborative approach augments the surveillance and response capability of individual nations, but the challenge of managing arbovirus risk with limited resources remains. In the absence of specific disease treatments and feasible vaccination solutions, mosquito control and personal protective measures are the mainstay of management programmes, albeit with variable success. In the long term, the development and integration of novel surveillance, diagnostic and mosquito control technologies will improve the capacity to prevent and respond to arbovirus threats
Functions and Mechanisms of the Human Ribosome-Translocon Complex
The membrane of the endoplasmic reticulum (ER) in human cells harbors the protein translocon, which facilitates membrane insertion and translocation of almost every newly synthesized polypeptide targeted to organelles of the secretory pathway. The translocon comprises the polypeptide-conducting Sec61 channel and several additional proteins, which are associated with the heterotrimeric Sec61 complex. This ensemble of proteins facilitates ER targeting of precursor polypeptides, Sec61 channel opening and closing, and modification of precursor polypeptides in transit through the Sec61 complex. Recently, cryoelectron tomography of translocons in native ER membranes has given unprecedented insights into the architecture and dynamics of the native, ribosome-associated translocon and the Sec61 channel. These structural data are discussed in light of different Sec61 channel activities including ribosome receptor function, membrane insertion or translocation of newly synthesized polypeptides as well as the possible roles of the Sec61 channel as a passive ER calcium leak channel and regulator of ATP/ADP exchange between cytosol and ER